← FDA Drug Approvals (Drugs@FDA)

MAVENCLAD

NDA · New Drug Application · Sponsor: EMD SERONO INC · Approved 2019-03-29

Drug application

FDA Application #

NDA022561

Application type

New Drug Application

Brand name

MAVENCLAD

Generic name

CLADRIBINE

Active ingredients

CLADRIBINE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

EMD SERONO INC

Manufacturer

EMD Serono, Inc.

First approval

2019-03-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown